Dr. Jim Tananbaum is the founder of Foresite Capital. He is an industry leader with over 25 years of experience building and investing in healthcare companies. Foresite Capital is an investment firm that provides growth capital to emerging healthcare companies across all sectors in both the private and public markets. Although Foresite Capital has an office in New York, it is based in San Francisco. Currently, the company has over $1.1 billion in assets under management.
Foresite Capital focuses on strategic opportunities to build franchise healthcare businesses. It has invested in different aspects of healthcare services such as biotechnology, diagnostics, genomics, healthcare services and medical devices. The company is always sourcing for the most qualified and experienced staffers to add to its human capital. Recently, Foresite Capital named Dr. Molly as the venture partner. She is a former senior director at Illumina. Dr. He brings more than 15 years of experience to Foresite. She focuses primarily on pharmaceutical and genomic research and development. Jim Tananbaum regards Dr. He as one of the most respected researchers in the area of next generation sequencing. Excited to join Foresite Capital Dr. He said she was to help grow the firm’s next generation sequencing portfolio.
About Jim Tananbaum,
Dr. Tananbaum holds an M.D. from Harvard Medical School and an M.B.A from Harvard Business School. While finishing medical school at Harvard, he founded GelTex Pharmaceuticals. The young company successfully brought two drugs to market for less than $80 million. Today these same drugs generate over $1 billion in revenues. While buying GelTex at $1.6 billion, Jim founded Theravance, Inc. The combined market capitalization of Theravance Biopharma and Theravance is $2.75 billion. You can visit About.me
Receiving tremendous success as an investor prompted Jim to start Prospect Venture Partners together with a few partners. In the past, Jim played a major role in the development of a healthcare service investment practice for Sierra Ventures. Dr. Tananbaum has led numerous investments including Amira Pharmaceuticals, Healtheon, Amerigroup, and Jazz Pharmaceuticals.
Midas List of Top Tech Investors in the Forbes Magazine has named Jim on their list for the past two years. The case was no different this year. Individuals who appear in the Midas List are among the top 100 venture capitalists whose aim is to work with futuristic tech companies from an early stage adding value exceptionally. Jim has been ranked as position 52 on this year’s list. During the last 25 years, Jim Tananbaum has founded, funded and helped numerous healthcare franchises to grow across all segments of the healthcare economy.
See more: https://ideamensch.com/jim-tananbaum/